Boostrix-Polio Product Monograph
Product Monograph Template - Schedule D]
Medicines Adverse Reactions Committee
Version: GDS09/IPI10
The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - eClinicalMedicine
Pertussis - NCIRS - National Centre for Immunisation Research and ...
Boostrix Product Monograph
File:Boostrix-IPV vaccine.jpg - Wikimedia Commons
Booster vaccination at 6-8 years of age with a reduced antigen content dTpa- IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine: Human Vaccines: Vol 4, No 1
Clinical Review Memo - BOOSTRIX
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ...
Local and general symptoms/signs after dTpa- IPV vaccination | Download Table
Antibody responses to diphtheria, tetanus toxoid and poliovirus types... | Download Table
e150 13th International Congress on Infectious Diseases Abstracts, Poster Presentations 19.026 Co-Administration of GSK's AS04
Vaccination against diphtheria, tetanus, pertussis (whooping cough) and polio (dtp-IPV vaccine)
Infanrix hexa, INN-Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults - ScienceDirect
AVOCA STREET MEDICAL CENTRE - RANDWICK SYDNEY - GP - 02 9399 3335 -
